Loading organizations...
Key people at Grand Yangtze Capital.
Grand Yangtze Capital operates as a private investment firm focused on U.S. and Asian markets. It employs a disciplined, research-driven approach to capital allocation, prioritizing capital preservation and long-term compounding. The strategy combines rigorous fundamental analysis with quantitative methods, identifying mispriced securities across public equity and fixed-income markets, informed by academic research in finance.
The firm was founded by Mrs. Yunhong Chen. Her insight emphasizes capital preservation as the primary objective, believing that disciplined adherence to a robust investment philosophy and strategic asset allocation are crucial for generating sustainable long-term returns, outperforming market fluctuations. This foundational principle guides all investment decisions.
Grand Yangtze Capital serves a sophisticated clientele seeking methodical investment management. The firm’s mission is to apply its disciplined process to achieve consistent, compounded growth for its partners. It maintains a long-term outlook, committed to a strategy prioritizing deep research and conviction for enduring success in dynamic global markets.
Key people at Grand Yangtze Capital.
Grand Yangtze Capital has 1 tracked investment across 1 company. The latest tracked deal is $19.0M Series A in InxMed in September 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 4, 2020 | InxMed | $19.0M Series A | China Growth Capital | — |